N-[[6-(5-chloro-3-pyridinyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(2-methoxy-1,3-thiazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-methyl-4,5-dihydro-1,2-oxazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-propan-2-yl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;1-[(6-phenylimidazo[1,2-b]pyridazin-3-yl)methyl]-4H-pyrrolo[3,2-b]pyridin-5-one
C99H84ClN37O7S2 — CID 160826399
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[6-(5-chloro-3-pyridinyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(2-methoxy-1,3-thiazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-methyl-4,5-dihydro-1,2-oxazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-propan-2-yl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;1-[(6-phenylimidazo[1,2-b]pyridazin-3-yl)methyl]-4H-pyrrolo[3,2-b]pyridin-5-one
N-[[6-(5-chloro-3-pyridinyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(2-methoxy-1,3-thiazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-methyl-4,5-dihydro-1,2-oxazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-propan-2-yl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;1-[(6-phenylimidazo[1,2-b]pyridazin-3-yl)methyl]-4H-pyrrolo[3,2-b]pyridin-5-one (PubChem CID 160826399) has the molecular formula C99H84ClN37O7S2 and a molecular weight of 2003.60 g/mol. Its IUPAC name is N-[[6-(5-chloro-3-pyridinyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(2-methoxy-1,3-thiazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-methyl-4,5-dihydro-1,2-oxazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-propan-2-yl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;1-[(6-phenylimidazo[1,2-b]pyridazin-3-yl)methyl]-4H-pyrrolo[3,2-b]pyridin-5-one.
Molecular Properties
| Compound Name | N-[[6-(5-chloro-3-pyridinyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(2-methoxy-1,3-thiazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-methyl-4,5-dihydro-1,2-oxazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-propan-2-yl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;1-[(6-phenylimidazo[1,2-b]pyridazin-3-yl)methyl]-4H-pyrrolo[3,2-b]pyridin-5-one |
|---|---|
| PubChem CID | 160826399 |
| Molecular Formula | C99H84ClN37O7S2 |
| Molecular Weight | 2003.60 g/mol |
| Exact Mass | 2001.65 |
| IUPAC Name | N-[[6-(5-chloro-3-pyridinyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-7-methoxy-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(2-methoxy-1,3-thiazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-methyl-4,5-dihydro-1,2-oxazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;7-methoxy-N-[[6-(3-propan-2-yl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine;1-[(6-phenylimidazo[1,2-b]pyridazin-3-yl)methyl]-4H-pyrrolo[3,2-b]pyridin-5-one |
| SMILES | COc1cnc2c(NCc3nnc4ccc(-c5cc(C(C)C)ns5)nn34)ccnc2c1.COc1cnc2c(NCc3nnc4ccc(-c5cncc(Cl)c5)nn34)ccnc2c1.COc1cnc2c(NCc3nnc4ccc(-c5csc(OC)n5)nn34)ccnc2c1.COc1cnc2c(NCc3nnc4ccc(C5CC(C)=NO5)nn34)ccnc2c1.O=c1ccc2c(ccn2Cc2cnc3ccc(-c4ccccc4)nn23)[nH]1 |
| InChI | InChI=1S/C21H20N8OS.C20H15ClN8O.C20H15N5O.C19H16N8O2S.C19H18N8O2/c1-12(2)16-9-18(31-28-16)14-4-5-19-25-26-20(29(19)27-14)11-23-15-6-7-22-17-8-13(30-3)10-24-21(15)17;1-30-14-7-17-20(25-10-14)16(4-5-23-17)24-11-19-27-26-18-3-2-15(28-29(18)19)12-6-13(21)9-22-8-12;26-20-9-7-18-17(22-20)10-11-24(18)13-15-12-21-19-8-6-16(23-25(15)19)14-4-2-1-3-5-14;1-28-11-7-14-18(22-8-11)13(5-6-20-14)21-9-17-25-24-16-4-3-12(26-27(16)17)15-10-30-19(23-15)29-2;1-11-7-16(29-26-11)13-3-4-17-23-24-18(27(17)25-13)10-21-14-5-6-20-15-8-12(28-2)9-22-19(14)15/h4-10,12H,11H2,1-3H3,(H,22,23);2-10H,11H2,1H3,(H,23,24);1-12H,13H2,(H,22,26);3-8,10H,9H2,1-2H3,(H,20,21);3-6,8-9,16H,7,10H2,1-2H3,(H,20,21) |
| InChIKey | SGFPTOJPTQCZCZ-UHFFFAOYSA-N |
| XLogP | 15.77 |
| TPSA | 497.95 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 45 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 146 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2003.60 |
| LogP ≤ 5 | 15.77 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 45 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160826399 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.